Stay updated with breaking news from Nasdaq Gmda. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Gamida Cell Ltd. (NASDAQ:GMDA – Get Free Report) saw a large growth in short interest during the month of January. As of January 15th, there was short interest totalling 7,930,000 shares, a growth of 19.1% from the December 31st total of 6,660,000 shares. Based on an average daily trading volume, of 2,940,000 shares, the short-interest […]
Gamida Cell (NASDAQ:GMDA – Get Free Report)‘s stock had its “market perform” rating restated by equities research analysts at JMP Securities in a research report issued on Monday, Benzinga reports. A number of other research analysts have also recently commented on GMDA. Piper Sandler dropped their target price on shares of Gamida Cell from $5.00 […]
Gamida Cell (NASDAQ:GMDA – Get Free Report) will announce its earnings results before the market opens on Tuesday, November 14th. Analysts expect the company to announce earnings of ($0.15) per share for the quarter. Investors interested in listening to the company’s conference call can do so using this link. Gamida Cell (NASDAQ:GMDA – Get Free […]
Data further characterize the mechanism for Gamida Cell’s proprietary nicotinamide (NAM) technology’s expansion and enhancement of cells...
Gamida Cell (NASDAQ:GMDA – Get Free Report) and SQZ Biotechnologies (NYSE:SQZ – Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, profitability, analyst recommendations, institutional ownership, risk, valuation and dividends. Earnings and Valuation This table compares Gamida […]